Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells

Cancer Biology & Therapy
Bailee H SlikerJoyce C Solheim

Abstract

Beta 2-microglobulin (β2m) is a component of the major histocompatibility complex (MHC) class I molecule, which presents tumor antigens to T lymphocytes to trigger cancer cell destruction. Notably, β2m has been reported as persistently expressed, rather than down regulated, in some tumor types. For renal cell and oral squamous cell carcinomas, β2m expression has been linked to increased migratory capabilities. The migratory ability of pancreatic cancer cells contributes to their metastatic tendencies and lethal nature. Therefore, in this study, we examined the impact of β2m on pancreatic cancer cell migration. We found that β2m protein is amply expressed in several human pancreatic cancer cell lines (S2-013, PANC-1, and MIA PaCa-2). Reducing β2m expression by short interfering RNA (siRNA) transfection significantly slowed the migration of the PANC-1 and S2-013 cancer cell lines, but increased the migration of the MIA PaCa-2 cell line. The amyloid precursor-like protein 2 (APLP2) has been documented as contributing to pancreatic cancer cell migration, invasiveness, and metastasis. We have previously shown that β2m/HLA class I/peptide complexes associate with APLP2 in S2-013 cells, and in this study we also detected their associa...Continue Reading

References

Dec 1, 1979·Cell·M S KrangelJ L Strominger
Jan 1, 1980·Medical and Pediatric Oncology·E H Cooper, T Plesner
Feb 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·E J CollinsD C Wiley
Sep 26, 1997·The Journal of Biological Chemistry·M D BurdickM A Hollingsworth
Sep 10, 1999·The Journal of Biological Chemistry·X F LiF S Yu
Nov 4, 2000·International Journal of Cancer. Journal International Du Cancer·S SatohM A Hollingsworth
May 23, 2001·The Journal of Surgical Research·X YangH E Appert
Dec 18, 2001·International Journal of Cancer. Journal International Du Cancer·K M McDermottM A Hollingsworth
Feb 19, 2003·Biochemical and Biophysical Research Communications·K M LeeM M Ouellette
Jul 2, 2003·The Journal of Biological Chemistry·Yunfei WenMichael A Hollingsworth
Jun 22, 2005·Neoplasia : an International Journal for Oncology Research·Rene HennigThomas E Adrian
Jan 18, 2006·Biochemical and Biophysical Research Communications·Michael B UjikiThomas E Adrian
May 19, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hideaki TsutsumidaMichael A Hollingsworth
Mar 21, 2007·Biochemical Society Transactions·D M WalshD J Selkoe
Oct 16, 2007·Molecular & Cellular Proteomics : MCP·Yu BaiGerold Schmitt-Ulms
Jul 16, 2008·The Journal of Biological Chemistry·Pankaj K SinghMichael A Hollingsworth
Jul 22, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Amit TuliJoyce C Solheim
Feb 3, 2009·Cancer Immunology, Immunotherapy : CII·Amit TuliJoyce C Solheim
Dec 9, 2010·Nature Biotechnology·Mathias UhlenFredrik Ponten
Jan 14, 2011·The Journal of Surgical Research·Laleh G MelstromDavid J Bentrem
Feb 19, 2011·American Journal of Physiology. Gastrointestinal and Liver Physiology·Vikas DudejaAshok K Saluja

❮ Previous
Next ❯

Datasets Mentioned

BETA
AA8110414

Methods Mentioned

BETA
xenograft
transfection
transfections
co-immunoprecipitation
immunoprecipitations
immunoprecipitation

Software Mentioned

COR Image Studio Lite
LI
Compass Simple

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.